Akron Rubber Development Laboratory.

A catheter developed at Akron Rubber Development Laboratory, as part of a joint venture with Shangrila Latex Industries of Bombay, India, could eliminate urinary tract infections in catheterized patients. Development and clinical studies are being funded by a grant from the Program for the Advancement of Commercial Technology (PACT), an initiative between the U.S. and Indian governments to support the development and commercialization of new technology. PACT granted ARDL $400,000 of the $800,000 needed to commercialize the catheter. Battelle is the U.S. advisor for the Industrial Credit and Investment Corporation of India, the administrator of PACT. PACT operates through the U.S. Agency for International Development-India.